WO2001072843A3 - Regulation of human c-myb-related genes - Google Patents

Regulation of human c-myb-related genes Download PDF

Info

Publication number
WO2001072843A3
WO2001072843A3 PCT/EP2001/003394 EP0103394W WO0172843A3 WO 2001072843 A3 WO2001072843 A3 WO 2001072843A3 EP 0103394 W EP0103394 W EP 0103394W WO 0172843 A3 WO0172843 A3 WO 0172843A3
Authority
WO
WIPO (PCT)
Prior art keywords
myb
human
related genes
regulation
anemias
Prior art date
Application number
PCT/EP2001/003394
Other languages
French (fr)
Other versions
WO2001072843A2 (en
Inventor
Jiing-Ren Liou
Original Assignee
Bayer Ag
Liou Jiing Ren
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag, Liou Jiing Ren filed Critical Bayer Ag
Priority to AU2001263810A priority Critical patent/AU2001263810A1/en
Publication of WO2001072843A2 publication Critical patent/WO2001072843A2/en
Publication of WO2001072843A3 publication Critical patent/WO2001072843A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Abstract

Human c-myb-related genes can be regulated to treat or prevent diseases of the hematopoietic system, such as such as anemias, including megaloblastic, normochromic and normocytic anemias, aplastic anemia, hemolytic disorders, thalassemias, hemoglobinopathies, and the like.
PCT/EP2001/003394 2000-03-27 2001-03-26 Regulation of human c-myb-related genes WO2001072843A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001263810A AU2001263810A1 (en) 2000-03-27 2001-03-26 Regulation of human c-myb-related genes

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19236700P 2000-03-27 2000-03-27
US60/192,367 2000-03-27

Publications (2)

Publication Number Publication Date
WO2001072843A2 WO2001072843A2 (en) 2001-10-04
WO2001072843A3 true WO2001072843A3 (en) 2002-06-13

Family

ID=22709355

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/003394 WO2001072843A2 (en) 2000-03-27 2001-03-26 Regulation of human c-myb-related genes

Country Status (2)

Country Link
AU (1) AU2001263810A1 (en)
WO (1) WO2001072843A2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5098890A (en) * 1988-11-07 1992-03-24 Temple University-Of The Commonwealth System Of Higher Education Antisence oligonucleotides to c-myb proto-oncogene and uses thereof
WO2000012702A2 (en) * 1998-08-31 2000-03-09 Bayer Corporation Human genes differentially expressed in colorectal cancer

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5098890A (en) * 1988-11-07 1992-03-24 Temple University-Of The Commonwealth System Of Higher Education Antisence oligonucleotides to c-myb proto-oncogene and uses thereof
WO2000012702A2 (en) * 1998-08-31 2000-03-09 Bayer Corporation Human genes differentially expressed in colorectal cancer

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE GENEMBL 19 March 1997 (1997-03-19), WESTIN,E.H. AND GORSE,K.M.: "Human (c-myb) gene, complete primary cds, and five complete alternatively spliced cds.", XP002187031 *
NOMURA N ET AL: "ISOLATION OF HUMAN COMPLEMENTARY DNA CLONES OF MYB-RELATED GENES A-MYB AND B-MYB", NUCLEIC ACIDS RESEARCH, vol. 16, no. 23, 1988, pages 11075 - 11090, XP001041811, ISSN: 0305-1048 *

Also Published As

Publication number Publication date
AU2001263810A1 (en) 2001-10-08
WO2001072843A2 (en) 2001-10-04

Similar Documents

Publication Publication Date Title
AU6974996A (en) Compositions for the treatment of dermatological disorders and methods for their use
WO2000018917A3 (en) α-SYNUCLEIN SUPER-MUTANTS ACCELERATE α-SYNUCLEIN AGGREGATION
MY131458A (en) Pyrolopyrimidine compounds
EP1213006A4 (en) Cosmetics
NZ297040A (en) Mono- or polyfunctional polylysine conjugates
AU5055096A (en) Dihydropyridazinones and pyridazinones and their use as fungicides and insecticides
AU2001294151A1 (en) System and method for the control of behavioral disorders
WO1997004788A3 (en) Use of calendula glycosides for the treatment of psoriasis
WO1999059617A3 (en) Immunoregulator
AU1906295A (en) Silica-based sols, preparation and use of the sols
IT1282778B1 (en) VITAMIN "E" ACETATE AS PRODUCT FOR TOPICAL APPLICATION
AU4774697A (en) Use of 1-hydroxy-2-pyridone for the treatment of seborrheic dermatitis
ZA985781B (en) Methods for using compositions containing dichlorophenyl imidazoldioxolan to treat seborrheic dermatitis, dandruff, psoriasis, and acne, and compositions thereof.
WO2001072843A3 (en) Regulation of human c-myb-related genes
AU2002304931A1 (en) Methods for treating disorders of the nervous and reproductive systems
AU4707101A (en) Method and system for online third party referral system customized to the purchaser's needs
WO1993005807A3 (en) Erythropoietin potentiating agents and methods for their use
AU7111400A (en) System and method for the diagnosis of respiratory disorders
AU5026600A (en) Methods of regulating the condition of mammalian keratinous tissue
IL105947A (en) Preparation of melanin in fluorocarbons for topical use and its production
WO2001047474A3 (en) Use of nano-scale deodorants
AU2001235706A1 (en) Cosmetic or medicinal composition containing sesquiterpene lactone or the like for treating hair-growth related disorders, and preparation method
AU2001294033A1 (en) Methods for treating disorders of the female reproductive system
AU1815695A (en) Animal model of the alzheimer disease, preparation and utilisations
AU8888198A (en) Human thrombopoietin produced by established human cell lines, process for producing the same, and medicinal compositions containing the same

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP